Table 2.

Oncogenic Circular RNA and Long Non-Coding RNAs (lncRNA), Which Act as Competitive Endogenous RNA (ceRNA) for miR-372 (So-Called Sponging Effect) in Different Cancers.

RNA	Malignancy	Cell Lines		No. of Tissue Samples (Pair)	Outcomes	References
		Normal	Cancerous
KCNQ1OT1	Lung adenocarcinoma	HEK293	A549, H1975	50	larger tumor, advanced clinical stage, and a lower response rate to concurrent therapy	[175]
OSER1-AS1	Hepatocellular Carcinoma	N/A	HepG2 and Hep3b	34	the proliferation, invasion and migration of HCC cells, and induced the apoptosis	[176]
LncRNA HULC	Hepatocellular Carcinoma	N/A	N/A	100	tumor node and metastases (TNM) higer stage, HCC recurrence, intra-hepatic metastases, and Lower postoperative survival.	[[62], [171]]
PCAT-14	Hepatocellular Carcinoma	LO2	Huh7, HCCLM3, HepG2, SMMC7721, PLC5, and QGY7701	120	proliferation and invasion of hepatocellular carcinoma cells	[66]
LncRNA HULC	Osteosarcoma	HfoB	SAOS-2 U2OS HoS MG63	32	Cell proliferation, migration and invasion of OS cells	[119]
Circ_0001721	Osteosarcoma	HfoB1.19	U2OS HoS	56	Tumor growth, proliferation, invasion, migration, EMT and promote cell apoptosis	[118]

N/A: Not Applicable.